SynCore Biotechnology Announces Interim Analysis Results for Novel Pancreatic Cancer Asset, SB05PC (EndoTAG®-1)
SynCore Biotechnology (4192:TT) receives interim analysis results for its [...]
SynCore Biotechnology (4192:TT) receives interim analysis results for its [...]